TherapeuticsMD
TXMD
#10160
Rank
A$30.31 M
Marketcap
A$2.62
Share price
8.07%
Change (1 day)
34.09%
Change (1 year)

TherapeuticsMD (TXMD) - Net assets

Net assets on the balance sheet as of June 2025 : A$41.08 Million

According to TherapeuticsMD's latest financial reports the company has A$41.08 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

TherapeuticsMD - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$44 M2.36%
2023-12-31$A$42.98 M-16.76%
2022-12-31$A$51.64 M-139.99%
2021-12-31$-A$0.13 Billion-19.92%
2020-12-31$-A$0.17 Billion-1327.11%
2019-12-31$A$13.14 M-90.51%
2018-12-31$A$0.13 B-16.81%
2017-12-31$A$0.16 B-5.92%
2016-12-31$A$0.17 B104.31%
2015-12-31$A$86.56 M46.41%
2014-12-31$A$59.12 M-3.58%
2013-12-31$A$61.32 M-4546.65%
2012-12-31$-A$1.38 Million-17.4%
2011-12-31$-A$1.67 Million-275.85%
2010-12-31$A$0.94 M-374.19%
2009-12-31$-A$0.35 Million-1406.6%
2008-12-31$A$0.02 M-94.45%
2007-12-31$A$0.47 M-77.69%
2006-12-31$A$2.14 M19.16%
2005-12-31$A$1.79 M32.2%
2004-12-31$A$1.35 M16.6%
2003-12-31$A$1.16 M-10.85%
2002-12-31$A$1.3 M-0.75%
2001-12-31$A$1.31 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agile Therapeutics
AGRX
-A$32.99 Million-180.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
-A$0.63 Billion-1,610.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$140.15 B 341,010.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-A$3.92 Billion-9,622.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
A$14.48 B 35,151.58%๐Ÿ‡ฌ๐Ÿ‡ง UK